You are here:

MS in the media - 19 January 2018

Published on

13 - 19 January 2018

These are links to news stories from the last week that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts

FDA finds against vitamin D and risk of MS claim

The FDA, the American drug regulator, has turned down a request from a pharmaceutical company for permission to say that consumption of vitamin D may reduce the risk of developing MS. The decision followed a review of the published research, which concluded that there is currently "no credible evidence" to support the claim

Source: FDA
Source: Food Navigator

MS Trust link: Vitamin D

Medical cannabis supported by Welsh Assembly

The Welsh Assembly has voted in favour of a motion to lobby the UK Government to make cannabis legal for medicinal use. The devolved government can't change the law itself. The articles include two people with MS talking about how cannabis has helped their symptoms

Source: Wales Online
Source: BBC

MS Trust link: Cannabis

Branded vs generic glatiramer study

Copaxone and a generic version of glatiramer acetate showed similar results for efficacy and side effects according to a recent study. The trial was needed to support the licence application for the generic version of the drug.

Source: Neurology Reviews

MS Trust link: Copaxone (glatiramer acetate)

Print this page